These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29307684)

  • 1. Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.
    Golan R; Bernstein A; Sedrakyan A; Daskivich TJ; Du DT; Ehdaie B; Fisher B; Gorin MA; Grunberger I; Hunt B; Jiang HH; Kim HL; Marinac-Dabic D; Marks LS; McClure TD; Montgomery JS; Parekh DJ; Punnen S; Scionti S; Viviano CJ; Wei JT; Wenske S; Wysock JS; Rewcastle J; Carol M; Oczachowski M; Hu JC
    J Urol; 2018 Jun; 199(6):1488-1493. PubMed ID: 29307684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
    Gross MD; Sedrakyan A; Bianco FJ; Carroll PR; Daskivich TJ; Eggener SE; Ehdaie B; Fisher B; Gorin MA; Hunt B; Jiang H; Klein EA; Marinac-Dabic D; Montgomery JS; Polascik TJ; Priester AM; Rastinehad AR; Viviano CJ; Wysock JS; Hu JC
    J Urol; 2019 Nov; 202(5):952-958. PubMed ID: 31144591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
    Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
    J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer.
    Klotz L; Pavlovich CP; Chin J; Hatiboglu G; Koch M; Penson D; Raman S; Oto A; Fütterer J; Serrallach M; Relle J; Lotan Y; Heidenreich A; Bonekamp D; Haider M; Tirkes T; Arora S; Macura KJ; Costa DN; Persigehl T; Pantuck AJ; Bomers J; Burtnyk M; Staruch R; Eggener S
    J Urol; 2021 Mar; 205(3):769-779. PubMed ID: 33021440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
    Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Ghai S; Finelli A; Corr K; Chan R; Jokhu S; Li X; McCluskey S; Konukhova A; Hlasny E; van der Kwast TH; Incze PF; Zlotta AR; Hamilton RJ; Haider MA; Kucharczyk W; Perlis N
    Radiology; 2021 Mar; 298(3):695-703. PubMed ID: 33529137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.
    Scheltema MJ; Tay KJ; Postema AW; de Bruin DM; Feller J; Futterer JJ; George AK; Gupta RT; Kahmann F; Kastner C; Laguna MP; Natarajan S; Rais-Bahrami S; Rastinehad AR; de Reijke TM; Salomon G; Stone N; van Velthoven R; Villani R; Villers A; Walz J; Polascik TJ; de la Rosette JJMCH
    World J Urol; 2017 May; 35(5):695-701. PubMed ID: 27637908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.
    Siddiqui KM; Billia M; Arifin A; Li F; Violette P; Chin JL
    J Urol; 2017 Jan; 197(1):97-102. PubMed ID: 27422297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
    Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
    BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
    Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
    Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.
    Bonekamp D; Wolf MB; Roethke MC; Pahernik S; Hadaschik BA; Hatiboglu G; Kuru TH; Popeneciu IV; Chin JL; Billia M; Relle J; Hafron J; Nandalur KR; Staruch RM; Burtnyk M; Hohenfellner M; Schlemmer HP
    Eur Radiol; 2019 Jan; 29(1):299-308. PubMed ID: 29943185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.
    Abreu AL; Peretsman S; Iwata A; Shakir A; Iwata T; Brooks J; Tafuri A; Ashrafi A; Park D; Cacciamani GE; Kaneko M; Duddalwar V; Aron M; Palmer S; Gill IS
    J Urol; 2020 Oct; 204(4):741-747. PubMed ID: 32898975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters.
    Hatiboglu G; Popeneciu V; Bonekamp D; Burtnyk M; Staruch R; Pahernik S; Tosev G; Radtke JP; Motsch J; Schlemmer HP; Hohenfellner M; Nyarangi-Dix JN
    World J Urol; 2020 Feb; 38(2):343-350. PubMed ID: 31062122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
    Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
    Valerio M; Dickinson L; Ali A; Ramachadran N; Donaldson I; Mccartan N; Freeman A; Ahmed HU; Emberton M
    J Urol; 2017 Mar; 197(3 Pt 1):647-654. PubMed ID: 27697580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
    Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
    J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.